Faruqi & Faruqi, LLP Announces Preliminary Approval Of Settlement In Rihn v. ACADIA Pharmaceuticals Inc.

Faruqi & Faruqi, LLP, sole lead counsel,  is pleased to announce that the Court has preliminarily approved a settlement in Rihn v. ACADIA Pharmaceuticals Inc., Case No.: 15-CV-00575-BTM-DHB.  The settlement provides for a cash payment of $2.925 million in exchange for the release of all claims alleged in the action.  As a result, notice will be sent to class members to advise them of their rights to participate in, object to, or seek exclusion from the settlement.  The final fairness hearing is scheduled for October 3, 2017.

If you purchased ACADIA common stock and/or call options between November 10, 2014 and March 11, 2015, both dates inclusive, and would like to discuss your legal rights, call Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or send an e-mail to rgonnello@faruqilaw.com.